NL187022B - Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat. - Google Patents

Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.

Info

Publication number
NL187022B
NL187022B NLAANVRAGE8102290,A NL8102290A NL187022B NL 187022 B NL187022 B NL 187022B NL 8102290 A NL8102290 A NL 8102290A NL 187022 B NL187022 B NL 187022B
Authority
NL
Netherlands
Prior art keywords
derivatives
pharmaceutical preparation
containing pharmaceutical
bacterial action
rifamycin
Prior art date
Application number
NLAANVRAGE8102290,A
Other languages
English (en)
Other versions
NL187022C (nl
NL8102290A (nl
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of NL8102290A publication Critical patent/NL8102290A/nl
Publication of NL187022B publication Critical patent/NL187022B/nl
Application granted granted Critical
Publication of NL187022C publication Critical patent/NL187022C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NLAANVRAGE8102290,A 1980-05-22 1981-05-11 Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat. NL187022C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT342980 1980-05-22
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (3)

Publication Number Publication Date
NL8102290A NL8102290A (nl) 1981-12-16
NL187022B true NL187022B (nl) 1990-12-03
NL187022C NL187022C (nl) 1991-05-01

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8102290,A NL187022C (nl) 1980-05-22 1981-05-11 Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.

Country Status (25)

Country Link
US (1) US4341785A (nl)
JP (1) JPS5711987A (nl)
AR (1) AR226212A1 (nl)
AT (1) AT373599B (nl)
AU (1) AU537093B2 (nl)
BE (1) BE888895A (nl)
CA (1) CA1142518A (nl)
CH (1) CH648037A5 (nl)
DE (1) DE3120460A1 (nl)
DK (1) DK157876C (nl)
EG (1) EG14891A (nl)
ES (1) ES502906A0 (nl)
FI (1) FI69467C (nl)
FR (1) FR2482967A1 (nl)
GB (1) GB2079270B (nl)
GR (1) GR75640B (nl)
IE (1) IE51204B1 (nl)
IT (1) IT1154655B (nl)
LU (1) LU83376A1 (nl)
NL (1) NL187022C (nl)
NO (1) NO155622C (nl)
PH (2) PH17207A (nl)
PT (1) PT73064B (nl)
SE (1) SE453089B (nl)
ZA (1) ZA813430B (nl)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
DE69829905T2 (de) * 1997-02-28 2006-03-09 Kaneka Corp. Heilmittel für durch Helicobacter verursachte Krankheit
WO2003045319A2 (en) * 2001-11-21 2003-06-05 Activbiotics, Inc. Targeted therapeutics and uses thereof
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
WO2004041240A1 (en) * 2002-11-05 2004-05-21 Piero Chiarelli Controlled and continued delivery of rifaximin and/or other substances
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
SI1698630T1 (sl) * 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0614758A2 (pt) 2005-08-11 2011-04-12 Targanta Therapeutics Inc rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso
ES2747259T3 (es) 2006-03-09 2020-03-10 Salix Pharmaceuticals Inc Preparación anti-disfunción rectal de rifaximina
PL2054066T3 (pl) 2006-08-02 2015-12-31 Salix Pharmaceuticals Inc Sposoby leczenia popromiennego zapalenia jelit
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
KR101667534B1 (ko) * 2006-09-22 2016-10-19 씨아이피엘에이 엘티디. 리팍시민
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
US8383151B2 (en) 2007-07-06 2013-02-26 Lupin Limited Pharmaceutical compositions of rifaximin
EP2837378A1 (en) 2007-07-06 2015-02-18 Lupin Limited Pharmaceutical compositions of rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
MX2010009389A (es) * 2008-02-25 2010-11-22 Salix Pharmaceuticals Ltd Formas de rifaximina y sus usos.
US8486956B2 (en) * 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
ES2727728T3 (es) 2008-02-26 2019-10-18 Salix Pharmaceuticals Ltd Métodos para el tratamiento del síndrome del intestino irritable
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
SI2294012T1 (sl) 2008-05-07 2014-11-28 Salix Pharmaceuticals, Ltd. Dajanje ÄŤistila za ÄŤrevo in antibiotika za zdravljenje ÄŤrevesne bolezni
US8524691B2 (en) 2008-08-13 2013-09-03 The Medicines Company Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
RU2011116400A (ru) 2008-09-26 2012-11-10 Аска Фармасьютикал Ко., Лтд. (Jp) Средство для предотвращения и/или лечения функционального расстройства желудочно-кишечного тракта
US20100204173A1 (en) 2008-10-02 2010-08-12 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
CA2745980C (en) 2008-12-10 2017-10-31 Cipla Limited Rifaximin complexes
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
MX2011012829A (es) 2009-06-02 2012-02-28 Salix Pharmaceuticals Ltd Metodos para tratar encefalopatia hepatica.
RU2582940C2 (ru) 2009-09-13 2016-04-27 Саликс Фармасьютикалз, Лтд. Способы лечения синдрома раздраженного кишечника (срк)
JP6211768B2 (ja) 2009-10-27 2017-10-11 ルピン・リミテッド リファキシミンの固溶体
WO2011061519A2 (en) 2009-11-23 2011-05-26 Cipla Limited Topical foam composition
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
JP5896380B2 (ja) 2010-02-18 2016-03-30 サリックス ファーマスーティカルズ，リミテッド 感染症を治療するための方法
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
JP6092629B2 (ja) 2010-03-10 2017-03-08 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ リファキシミン使用準備済懸濁液
PL2593463T3 (pl) 2010-07-12 2020-11-02 Salix Pharmaceuticals, Inc. Formulacje ryfaksyminy i ich zastosowania
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
KR20140026379A (ko) 2011-02-11 2014-03-05 샐릭스 파마슈티컬스 리미티드 리팍시민의 형태 및 이의 용도
EP2705042A1 (en) 2011-05-02 2014-03-12 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
AU2012332211B2 (en) 2011-11-02 2016-11-24 Salix Pharmaceuticals, Ltd. Methods for treating irritable bowel syndrome (IBS) and infections
CA2861104A1 (en) * 2012-01-25 2013-08-01 Salix Pharmaceuticals, Ltd. Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
WO2014140995A2 (en) 2013-03-15 2014-09-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
EP2968283A1 (en) 2013-03-15 2016-01-20 ALFA WASSERMANN S.p.A. Rifaximin for use in the treating of vaginal infections.
EP2983647B1 (en) 2013-04-12 2020-09-09 Alfasigma S.p.A. Nsaid administration and related compositions, methods and systems
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
EP3140313B1 (en) 2014-05-04 2020-02-26 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
PT3143027T (pt) * 2014-05-12 2019-09-20 Alfasigma Spa Nova forma de cristal solvatado de rifaximina, produção, composições e utilização dos mesmos
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
KR20240124428A (ko) 2016-09-30 2024-08-16 샐릭스 파마슈티컬스 인코포레이티드 리팍시민의 고체 분산물 형태
RU2020102511A (ru) * 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (nl) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
FI69467C (fi) 1986-02-10
DE3120460A1 (de) 1982-03-11
IE811139L (en) 1981-11-22
PH17207A (en) 1984-06-19
NO155622C (no) 1987-04-29
ES8203388A1 (es) 1982-04-01
GB2079270B (en) 1984-01-18
FI811565L (fi) 1981-11-23
ZA813430B (en) 1982-06-30
FI69467B (fi) 1985-10-31
FR2482967B1 (nl) 1985-03-29
IE51204B1 (en) 1986-10-29
AT373599B (de) 1984-02-10
DK157876B (da) 1990-02-26
ATA222781A (de) 1983-06-15
NL187022C (nl) 1991-05-01
AR226212A1 (es) 1982-06-15
IT1154655B (it) 1987-01-21
NO155622B (no) 1987-01-19
CH648037A5 (de) 1985-02-28
AU7065581A (en) 1981-11-26
IT8003429A0 (it) 1980-05-22
AU537093B2 (en) 1984-06-07
DE3120460C2 (nl) 1990-12-13
DK224781A (da) 1981-11-23
JPS5711987A (en) 1982-01-21
CA1142518A (en) 1983-03-08
NL8102290A (nl) 1981-12-16
LU83376A1 (fr) 1981-09-11
JPS6123192B2 (nl) 1986-06-04
US4341785A (en) 1982-07-27
PH18704A (en) 1985-09-05
EG14891A (en) 1985-12-31
SE453089B (sv) 1988-01-11
DK157876C (da) 1990-07-30
ES502906A0 (es) 1982-04-01
GR75640B (nl) 1984-08-02
NO811731L (no) 1981-11-23
FR2482967A1 (fr) 1981-11-27
PT73064A (en) 1981-06-01
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
BE888895A (fr) 1981-09-16
GB2079270A (en) 1982-01-20

Similar Documents

Publication Publication Date Title
NL187022C (nl) Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
FI863797A (fi) Peptidas specifik foer n-terminal mentionin, producering och anvaendning av densamma.
NO801863L (no) Farmasoeytiske preparater.
NL300038I2 (nl) Thiazolidinedionderivaten, alsmede bereiding en toepassing daarvan.
NL190580B (nl) Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten.
FI822005A0 (fi) Antifungisida aemnen, foerfarande foer deras framstaellning, och dessa innehaollande farmaceutiska sammansaettningar
FI862644A0 (fi) Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.
IT8222771A0 (it) Siringa.
NL186697C (nl) 1,3-dihydro-6-methyl-7-hydroxyfuro-(3,4-c)-pyridinederivaat, dat op de 3-plaats gesubstitueerd is en een diuretische werking heeft en farmaceutisch preparaat met diuretische werking.
NL185622B (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede 7beta-acylamino-7alfa-methoxy-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur.
FI823544A0 (fi) Triazinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar
NL191777C (nl) Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking.
IT8019740A0 (it) Derivati benzoazepinici.
NL192740B (nl) Oxadethiacefalosporinederivaat met antibacteriële werking, alsmede bereidingswijze daarvoor en antibacteriaal preparaat daaruit.
NL185923C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede penam-3-carbonzuur-1,1-dioxyde-derivaat.
NL192926B (nl) Cefalosporinederivaat met antibacteriële werking, en farmaceutisch preparaat daaruit.
NL192111B (nl) Geneesmiddelpreparaat met anti-inflammatoire werking.
NL191744C (nl) Farmaceutisch preparaat met werking tegen epitheelletsels.
FI870293A (fi) 8 -acylaminoergoliner, deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
NL7902993A (nl) Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.
NO811003L (no) Farmasoeytiske preparater.
FI855131A (fi) 8-acylaminoergoliner, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma.
NL193821B (nl) Farmaceutisch preparaat.
FI850803L (fi) Aminodiarylsulfoxiderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska och pesticida foereningar.
IT8323472A0 (it) Derivati epossicarbaciclinici, loro preparazione e loro uso.

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
BA A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010511